NCT00849394 Evaluation of Protein in the Urine in Patients Receiving Bevacizumab Status COMPLETED Phase N/A
NCT00845039 A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab Status TERMINATED Phase PHASE2
NCT00826800 Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer Status TERMINATED Phase NA
NCT00819780 PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors Status COMPLETED Phase PHASE2
NCT00807313 Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT00788957 Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE1/PHASE2
NCT00774839 Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients Status COMPLETED Phase N/A
NCT00766220 Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver Status WITHDRAWN Phase PHASE2
NCT00756977 BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Status COMPLETED Phase PHASE3
NCT00756548 BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Status COMPLETED Phase PHASE3
NCT00752570 A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00715325 ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy Status UNKNOWN Phase PHASE1/PHASE2
NCT00695201 Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00687830 Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy. Status COMPLETED Phase PHASE3